|
|
|
|
| www.smw.ch |
|
|
|
Henzen C. Treatment of type 2 diabetes with glitazones – first do no harm? [154] |
|
|
|
|
|
McShane H. Vaccine strategies against tuberculosis [156] |
|
|
|
|
|
Isler R, Romerio S, Halter U, Heiniger S, Persike M, Röers B, Bally K, Martina B, Tschudi P. One-on-one long-term tutorials in general practitioners practice – a successful new teaching concept in primary care medicine [161] |
|
|
Gruber M, Christ-Crain M, Stolz D, Keller U, Müller C, Bingisser R, Tamm M, Mueller B, Schuetz P. Prognostic impact of plasma lipids in patients with lower respiratory tract infections - an observational study [166] |
|
|
Brändle M, Goodall G, Erny-Albrecht KM, Erdmann E, Valentine WJ. Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting [173] |
|
|
Copyright © 2009 EMH Swiss Medical Publishers Ltd. |
Top